Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2001 2
2002 3
2003 4
2004 3
2005 3
2006 6
2007 4
2008 2
2009 3
2011 2
2012 2
2013 6
2014 3
2015 6
2016 8
2017 8
2018 12
2019 18
2020 10
2021 12
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
Circulating biomarkers for early detection and clinical management of colorectal cancer.
Marcuello M, Vymetalkova V, Neves RPL, Duran-Sanchon S, Vedeld HM, Tham E, van Dalum G, Flügen G, Garcia-Barberan V, Fijneman RJ, Castells A, Vodicka P, Lind GE, Stoecklein NH, Heitzer E, Gironella M. Marcuello M, et al. Among authors: gironella m. Mol Aspects Med. 2019 Oct;69:107-122. doi: 10.1016/j.mam.2019.06.002. Epub 2019 Jun 14. Mol Aspects Med. 2019. PMID: 31189073 Free article. Review.
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.
Rosiñol L, Oriol A, Rios R, Sureda A, Blanchard MJ, Hernández MT, Martínez-Martínez R, Moraleda JM, Jarque I, Bargay J, Gironella M, de Arriba F, Palomera L, González-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, González AP, Casado LF, López-Anglada L, Paiva B, Mateos MV, San Miguel JF, Lahuerta JJ, Bladé J. Rosiñol L, et al. Among authors: gironella m. Blood. 2019 Oct 17;134(16):1337-1345. doi: 10.1182/blood.2019000241. Blood. 2019. PMID: 31484647 Free PMC article. Clinical Trial.
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Grosicki S, Simonova M, Spicka I, Pour L, Kriachok I, Gavriatopoulou M, Pylypenko H, Auner HW, Leleu X, Doronin V, Usenko G, Bahlis NJ, Hajek R, Benjamin R, Dolai TK, Sinha DK, Venner CP, Garg M, Gironella M, Jurczyszyn A, Robak P, Galli M, Wallington-Beddoe C, Radinoff A, Salogub G, Stevens DA, Basu S, Liberati AM, Quach H, Goranova-Marinova VS, Bila J, Katodritou E, Oliynyk H, Korenkova S, Kumar J, Jagannath S, Moreau P, Levy M, White D, Gatt ME, Facon T, Mateos MV, Cavo M, Reece D, Anderson LD Jr, Saint-Martin JR, Jeha J, Joshi AA, Chai Y, Li L, Peddagali V, Arazy M, Shah J, Shacham S, Kauffman MG, Dimopoulos MA, Richardson PG, Delimpasi S. Grosicki S, et al. Among authors: gironella m. Lancet. 2020 Nov 14;396(10262):1563-1573. doi: 10.1016/S0140-6736(20)32292-3. Lancet. 2020. PMID: 33189178 Clinical Trial.
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.
Medina A, Puig N, Flores-Montero J, Jimenez C, Sarasquete ME, Garcia-Alvarez M, Prieto-Conde I, Chillon C, Alcoceba M, Gutierrez NC, Oriol A, Rosinol L, Bladè J, Gironella M, Hernandez MT, Gonzalez-Calle V, Cedena MT, Paiva B, San-Miguel JF, Lahuerta JJ, Mateos MV, Martinez-Lopez J, Orfao A, Gonzalez M, Garcia-Sanz R. Medina A, et al. Among authors: gironella m. Blood Cancer J. 2020 Oct 30;10(10):108. doi: 10.1038/s41408-020-00377-0. Blood Cancer J. 2020. PMID: 33127891 Free PMC article. Clinical Trial.
Reply.
Castells A, Gironella M. Castells A, et al. Among authors: gironella m. Clin Gastroenterol Hepatol. 2021 Jul 3:S1542-3565(21)00714-X. doi: 10.1016/j.cgh.2021.07.003. Online ahead of print. Clin Gastroenterol Hepatol. 2021. PMID: 34229036 No abstract available.
Molecular markers in pancreatic cancer diagnosis.
Herreros-Villanueva M, Gironella M, Castells A, Bujanda L. Herreros-Villanueva M, et al. Among authors: gironella m. Clin Chim Acta. 2013 Mar 15;418:22-9. doi: 10.1016/j.cca.2012.12.025. Epub 2013 Jan 8. Clin Chim Acta. 2013. PMID: 23305796 Review.
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis.
Cuenca I, Alameda D, Sanchez-Vega B, Gomez-Sanchez D, Alignani D, Lasa M, Onecha E, Lecumberri R, Prosper F, Ocio EM, González ME, García de Coca A, De La Rubia J, Gironella M, Palomera L, Oriol A, Casanova M, Cabañas V, Taboada F, Pérez-Montaña A, De Arriba F, Puig N, Carreño-Tarragona G, Barrio S, Enrique de la Puerta J, Ramirez-Payer A, Krsnik I, Bargay JJ, Lahuerta JJ, Mateos MV, San-Miguel JF, Paiva B, Martinez-Lopez J. Cuenca I, et al. Among authors: gironella m. Leukemia. 2021 Jan;35(1):245-249. doi: 10.1038/s41375-020-0800-6. Epub 2020 Mar 19. Leukemia. 2021. PMID: 32203144 Free PMC article. No abstract available.
Probing cellular mechanics with acoustic force spectroscopy.
Sorkin R, Bergamaschi G, Kamsma D, Brand G, Dekel E, Ofir-Birin Y, Rudik A, Gironella M, Ritort F, Regev-Rudzki N, Roos WH, Wuite GJL. Sorkin R, et al. Among authors: gironella m. Mol Biol Cell. 2018 Aug 8;29(16):2005-2011. doi: 10.1091/mbc.E18-03-0154. Epub 2018 Jun 21. Mol Biol Cell. 2018. PMID: 29927358 Free PMC article.
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S, Moreno L, Gómez-Matas J, Augé JM, Serra-Burriel M, Cuatrecasas M, Moreira L, Serradesanferm A, Pozo À, Grau J, Pellisé M, Gironella M, Castells A. Duran-Sanchon S, et al. Among authors: gironella m. Clin Gastroenterol Hepatol. 2021 Feb;19(2):323-330.e1. doi: 10.1016/j.cgh.2020.02.043. Epub 2020 Feb 28. Clin Gastroenterol Hepatol. 2021. PMID: 32113893 Free article.
103 results